Evidence map›Paper›PMID 42783458›Full record

ReviewMedical sciences (Basel, Switzerland)2026

Pleomorphism in Soft Tissue Sarcomas: Molecular Characteristics and Clinical Features.

Elena E Kopantseva, Alexey S Rzhevskiy, Ekaterina A Lesovaya, Vlada E Tuliavko, Nikolay A Kozlov, Timur I Fetisov, Kirill I Kirsanov, Evgeny V Denisov, Marianna G Yakubovskaya

Abstract readReview
In one paragraph

Review in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elena E KopantsevaResearch Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow 115093, Russia.ORCID 0000-0002-5618-4588
Alexey S RzhevskiyResearch Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow 115093, Russia.
Ekaterina A LesovayaResearch Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow 115093, Russia.ORCID 0000-0002-1967-9637
Vlada E TuliavkoResearch Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow 115093, Russia.
Nikolay A KozlovResearch Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow 115093, Russia.
Timur I FetisovResearch Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow 115093, Russia.
Kirill I KirsanovResearch Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow 115093, Russia.
Evgeny V DenisovResearch Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow 115093, Russia.
Marianna G YakubovskayaResearch Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow 115093, Russia.ORCID 0000-0002-9710-8178

Funding

Russian Science Foundation 23-65-00003
6 · The paper itself

Abstract

Pleomorphism in cells encompasses a variety of morphological features, such as heterogeneity in the size and shape of cells and nuclei, irregularity of the nuclear membrane, hyperchromasia, and peculiarities of cell organelles. Pleomorphism in mammalian cells is associated with genetically unstable neoplasms and is frequently accompanied by high rates of proliferation and low differentiation status. Among soft tissue sarcomas, a group of tumors characterized by the pleomorphic phenotype can be distinguished. Pleomorphic soft tissue sarcomas are a rare, understudied group of soft tissue sarcomas with aggressive behavior, low survival rates, and high resistance to standard chemotherapy treatment. Knowledge of the mechanisms behind the pleomorphic features, common genetic and epigenetic alterations, and their association with aggressive tumorigenesis is essential for advancing patient care for this group of sarcomas. In this narrative review, we consolidate existing evidence concerning clinical features of pleomorphic sarcomas, their possible histogenesis, the common drivers and transcriptional networks, and the potentially available approaches for treatment.

Indexed as

SarcomaHumansgenomicspleomorphismsoft tissue sarcomatherapeutic advancestranscriptomics

Identifiers

PMID42783458
PMCPMC13609418

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.